{'fraction_non_alphanumeric': 0.025552486187845305, 'fraction_numerical': 0.007596685082872928, 'mean_word_length': 5.497757847533633, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
COVID-19 and endocrinopathies

In general, it is rare for an endocrine physician to be at the fore-front of any pandemic, as most of the acutely ill patients are managed by first responders and emergency physicians. With increasing evidence that patients having endocrine and metabolic disorders, especially uncontrolled, are the ones expected to have poorer outcomes during the ongoing coronavirus disease 2019 (COVID-19) pandemic, it has brought the endocrine physician to the fore-front of management. Several publications have reported the endocrine and metabolic conditions that may be considered risk factors for acquiring the new coronavirus (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2]) infection, but the direct evidence whether SARS-CoV-2 may directly lead to endocrinopathies causing disorders that make the prognosis of affected patients worse, are lacking. Most of the endocrine disorders, but their etiopathogenesis or treatment thereof alter the way the body's immune defense mechanisms are triggered. Furthermore, in specific scenarios, ongoing treatment may have to be discontinued/modified. There is still paucity of data to alter the already available “best practices or clinical recommendations” statements. In the absence of any specific recommendations, it is the left to the judgment of the treating endocrine physician to adapt the available recommendations/guidelines on the basis of the clinical judgment.